Living Cell Technologies Ltd. (LVCLY: OTCQX International) | Half Yearly Report and Accounts

Carbon Natural Gas Company (CRBO: OTCQB) | Carbon Natural Gas Company Announces Formation of Carbon California Company, LLC and Acquisition of Oil Producing Assets and Related Financing

Fortescue Metals Group Ltd (FSUGY: OTCQX International Premier) | FY17 Half Year Media Release

Granite Oil Corp (GXOCF: OTCQX International) | Granite Oil Corp. Announces Record 2016 Year End Reserve Metrics and Operational Update

SQI Diagnostics Inc. (SQIDF: OTCQX International) | SQI Diagnostics Reports First Quarter 2017 Results

OTC Markets Group Inc. (OTCM: OTCQX U.S. Premier) | OTC Markets Group Announces Fourth Quarter and Year End 2016 Earnings Release and Conference Call

SQI Diagnostics Inc. (SQIDF: OTCQX International) | SQI Diagnostics Reports First Quarter 2017 Results

M Pharmaceutical Inc. Appoints Mr. William A. Rodgers Jr., of Milton, Georgia to its Board of Directors

VANCOUVER, BC / ACCESSWIRE / February 21, 2017 / M Pharmaceutical Inc. (CNSX: MQ, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “M Pharma”) President and CEO, Mr. Gary Thompson, announces that Mr. William A. Rodgers Jr., of Milton, Georgia, has …

MorphoSys's Subsidiary Lanthio Pharma Initiates First-in-Human Clinical Study with Lanthipeptide MOR107

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / February 21, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY) announced today that its fully owned subsidiary Lanthio Pharma B.V., Groningen, Netherlands, has initiated a phase 1 clinical study with …

Asiamet Resources Strengthens Board and Management

VANCOUVER, BC / ACCESSWIRE / February 21, 2017 / Asiamet Resources Limited (“ARS” or the “Company”) (TSX-V and AIM: ARS) is pleased to announce a further strengthening of its Board and management team as it advances the BKM feasibility study …